rawfin.tv
Entrada Therapeutics R&D President Sells $398,809 in Company Shares
MarketsstocksAI Generated

Entrada Therapeutics R&D President Sells $398,809 in Company Shares

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Sethuraman Natarajan, President of Research & Development at Entrada Therapeutics, Inc., sold 25,907 shares totaling $398,809. This insider selling activity is a notable transaction for the company.

Entrada TherapeuticsInsider SellingBiotechnologyShare SalesCorporate Governance

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks